(Q71586107)
Statements
Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis (English)
E J Gordon
K J Myers
J P Dougherty
H Rosen
1 November 1995
scientific article published on 01 November 1995